ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE NICKLES GROUP, LLC	—	10

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	9
SENATE	9
Centers For Medicare and Medicaid Services (CMS)	7
Health & Human Services, Dept of (HHS)	7
Office of Management & Budget (OMB)	7
U.S. Trade Representative (USTR)	7
White House Office	7
Executive Office of the President (EOP)	6
Commerce, Dept of (DOC)	5
Treasury, Dept of	5
Council of Economic Advisers (CEA)	1
Natl Economic Council (NEC)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	10
Trade (domestic/foreign)	Trade (domestic/foreign)	7
Health Issues	Health Issues	2
Defense	Defense	1

Bills Explicitly Cited (16)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5343119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act

2026 · third_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare coverage of breakthrough technologies. Issues related to the RAPID coverage pathway. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to Medicare durable medical equipment competitive bidding and coverage of diabetes technologies. The FY2027 IPPS final rule and issues related to new technology add-on payments.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5343

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair and restrictions on stock buybacks and dividends.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 8800

S. 1717119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

2026 · third_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare coverage of breakthrough technologies. Issues related to the RAPID coverage pathway. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to Medicare durable medical equipment competitive bidding and coverage of diabetes technologies. The FY2027 IPPS final rule and issues related to new technology add-on payments.

Client expense: — · Firm income: $60,000

Matched citations: S. 1717

S. 4784119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair and restrictions on stock buybacks and dividends.

Client expense: — · Firm income: $60,000

Matched citations: S. 4784

Show 12 more cited filings

H.R. 5343119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act

2026 · second_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare coverage of breakthrough technologies. Issues related to the RAPID coverage pathway. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to Medicare durable medical equipment competitive bidding and coverage of diabetes technologies. The FY2027 IPPS proposed rule and issues related to new technology add-on payments.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5343

S. 1717119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

2026 · second_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare coverage of breakthrough technologies. Issues related to the RAPID coverage pathway. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to Medicare durable medical equipment competitive bidding and coverage of diabetes technologies. The FY2027 IPPS proposed rule and issues related to new technology add-on payments.

Client expense: — · Firm income: $60,000

Matched citations: S. 1717

H.R. 5343119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act

2026 · first_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues relates to Medicare coverage of breakthrough technologies. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to Medicare durable medical equipment competitive bidding.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5343

S. 1717119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

2026 · first_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues relates to Medicare coverage of breakthrough technologies. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to Medicare durable medical equipment competitive bidding.

Client expense: — · Firm income: $60,000

Matched citations: S. 1717

H.R. 5343119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act

2025 · fourth_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues relates to Medicare coverage of breakthrough technologies. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to the CY 2026 Medicare Home Health Rule.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5343

S. 1717119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

2025 · fourth_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues relates to Medicare coverage of breakthrough technologies. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to the CY 2026 Medicare Home Health Rule.

Client expense: — · Firm income: $60,000

Matched citations: S. 1717

H.R. 5343119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act

2025 · third_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues relates to Medicare coverage of breakthrough technologies. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5343

S. 1717119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

2025 · third_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues relates to Medicare coverage of breakthrough technologies. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025.

Client expense: — · Firm income: $60,000

Matched citations: S. 1717

S. 1717119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

2025 · second_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues relates to Medicare coverage of breakthrough technologies. S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025.

Client expense: — · Firm income: $60,000

Matched citations: S. 1717

H.R. 10445118th Congress

Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025

2024 · fourth_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. H.R. 10445, Furthering Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025, as it relates to Medicare coverage of breakthrough technologies.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 10445

H.R. 1691118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

2024 · fourth_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. H.R. 10445, Furthering Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025, as it relates to Medicare coverage of breakthrough technologies.

Client expense: — · Firm income: $60,000

Matched citations: H.R.1691

H.R. 1691118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

2024 · third_quarter · Firm: THE NICKLES GROUP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: H.R.1691

Source: Senate LDA

ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) — Lobbying Disclosure | Poliscope